nephrology · Mechanism Report

Do SDMA and UACR provide complementary information about kidney health?

Symmetric dimethylarginine and urinary albumin-to-creatinine ratio assess different but complementary aspects of kidney health: filtration and kidney damage.

PlausibleSeptember 16, 20263 Sources

This is what AI claimed

Symmetric dimethylarginine and the urinary albumin-to-creatinine ratio provide complementary information about kidney filtration and kidney damage, respectively.

2 of 3 paths supported

Executive summary

The claim says SDMA reflects kidney filtration, while UACR reflects albumin-related kidney damage. The mechanism framing supports this split by linking SDMA to reduced renal clearance and UACR to abnormal urinary albumin loss, which can occur even when filtration is still preserved. Together, they are described as measuring related but distinct dimensions of kidney health.

Verified conclusion

Symmetric dimethylarginine (SDMA) and urinary albumin-to-creatinine ratio (UACR) assess different but clinically related dimensions of kidney health: filtration and albuminuric damage. This distinction is biologically coherent and supported by clinical evidence.

Clinical evidence

SDMA reflects filtration-related physiology. It is predominantly eliminated by the kidneys and increases as GFR falls. A meta-analysis of 18 studies (n=2,136) found a strong correlation between SDMA and inulin clearance (r=0.85; 95% CI, 0.76–0.91). In a heterogeneous adult cohort, SDMA correlated inversely with iothalamate-measured GFR (r=−0.84), comparable with cystatin C and stronger than creatinine in that study.
UACR reflects kidney damage through albuminuria. Persistent UACR ≥30 mg/g is a CKD diagnostic criterion. Its categories—A1 <30 mg/g, A2 30–300 mg/g, and A3 >300 mg/g—are used for CKD classification and risk assessment.

Mechanistic and practical interpretation

SDMA rises when renal clearance declines, linking it to filtration rather than directly to structural injury.
UACR detects abnormal urinary albumin loss, a manifestation of glomerular and/or renal damage that may occur with preserved GFR. Thus, a person can have an abnormal UACR despite apparently maintained filtration, or reduced filtration without substantial albuminuria.
An elevated UACR should be confirmed—preferably using a first-morning sample—because transient variation can occur.

Clinical implications

Current KDIGO-oriented assessment remains GFR estimation using creatinine, with creatinine–cystatin C methods when appropriate, plus UACR. SDMA is not currently a routine guideline-endorsed replacement for measured GFR or established eGFR methods.

Bottom line

SDMA and UACR do provide complementary information about filtration and kidney damage, respectively. SDMA’s role is promising as a filtration biomarker, but evidence does not establish that adding SDMA to standard GFR assessment plus UACR improves clinical decisions or outcomes.

References

See a full patient report verified like this

Book a walkthrough

Executive summary

Verified conclusion

Clinical evidence

SDMA reflects filtration-related physiology. It is predominantly eliminated by the kidneys and increases as GFR falls. A meta-analysis of 18 studies (n=2,136) found a strong correlation between SDMA and inulin clearance (r=0.85; 95% CI, 0.76–0.91). In a heterogeneous adult cohort, SDMA correlated inversely with iothalamate-measured GFR (r=−0.84), comparable with cystatin C and stronger than creatinine in that study.
UACR reflects kidney damage through albuminuria. Persistent UACR ≥30 mg/g is a CKD diagnostic criterion. Its categories—A1 <30 mg/g, A2 30–300 mg/g, and A3 >300 mg/g—are used for CKD classification and risk assessment.

Mechanistic and practical interpretation

SDMA rises when renal clearance declines, linking it to filtration rather than directly to structural injury.
UACR detects abnormal urinary albumin loss, a manifestation of glomerular and/or renal damage that may occur with preserved GFR. Thus, a person can have an abnormal UACR despite apparently maintained filtration, or reduced filtration without substantial albuminuria.
An elevated UACR should be confirmed—preferably using a first-morning sample—because transient variation can occur.

Clinical implications

Current KDIGO-oriented assessment remains GFR estimation using creatinine, with creatinine–cystatin C methods when appropriate, plus UACR. SDMA is not currently a routine guideline-endorsed replacement for measured GFR or established eGFR methods.

Bottom line

SDMA and UACR do provide complementary information about filtration and kidney damage, respectively. SDMA’s role is promising as a filtration biomarker, but evidence does not establish that adding SDMA to standard GFR assessment plus UACR improves clinical decisions or outcomes.